Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Canadian Medical Association Journal, Toronto

Canadian Medical Association Journal, Toronto to effect tumor cells eler's failed reveal the antiserum was to rings any anti-inflammatory complement, cytotaxic which that could be attributed to indomethacin with statis¬ in vitro. Mice inoculated with Ehrlich ascites any cells, dem¬ tical The detumescent and effects had been incubated with the fraction of the validity. analgesic 7-globulin to onstrated are shown be the result of and learn¬ antiserum with iodine did not placebo coupled 131, develop tumor, factors. A of indomethacin accelerate the and have remained for weeks. In ing tendency to healthy several contrast, rate of sedimentation was and evi¬ mice inoculated erythrocyte revealed, with tumor or with tumor incu¬ alone, dence for a effect in rheumatoid ar¬ bated with specific antifatigue non-iodinated with or without com¬ antiserum, thritic is type, and or with iodinated nonimmune patients presented. Incidence, pattern plement, globulin invariably of side effects to be similar with both and ascites and died within 14 of inocu¬ proved drug developed tumor days a in deter¬ lation. placebo. Suggestion probably played large part incidence and of side effects encountered mining variety in of these on many patients. Dextromoramide—R. and Dependence Seymour-Shove C. W. M. Wilson of Col¬ (Dept Pharmacology, Trinity Conservative for Ulcer—R. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Canadian Medical Association Journal, Toronto

JAMA , Volume 199 (8) – Feb 20, 1967

Loading next page...
 
/lp/american-medical-association/canadian-medical-association-journal-toronto-x5s06i05G5

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1967 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1967.03120080143049
Publisher site
See Article on Publisher Site

Abstract

to effect tumor cells eler's failed reveal the antiserum was to rings any anti-inflammatory complement, cytotaxic which that could be attributed to indomethacin with statis¬ in vitro. Mice inoculated with Ehrlich ascites any cells, dem¬ tical The detumescent and effects had been incubated with the fraction of the validity. analgesic 7-globulin to onstrated are shown be the result of and learn¬ antiserum with iodine did not placebo coupled 131, develop tumor, factors. A of indomethacin accelerate the and have remained for weeks. In ing tendency to healthy several contrast, rate of sedimentation was and evi¬ mice inoculated erythrocyte revealed, with tumor or with tumor incu¬ alone, dence for a effect in rheumatoid ar¬ bated with specific antifatigue non-iodinated with or without com¬ antiserum, thritic is type, and or with iodinated nonimmune patients presented. Incidence, pattern plement, globulin invariably of side effects to be similar with both and ascites and died within 14 of inocu¬ proved drug developed tumor days a in deter¬ lation. placebo. Suggestion probably played large part incidence and of side effects encountered mining variety in of these on many patients. Dextromoramide—R. and Dependence Seymour-Shove C. W. M. Wilson of Col¬ (Dept Pharmacology, Trinity Conservative for Ulcer—R.

Journal

JAMAAmerican Medical Association

Published: Feb 20, 1967

There are no references for this article.